In the U.S. today, approximately 27% of the adult population deals with the painful symptoms of GERD 1, and 40% of GERD patients don't respond to the most common medication to treat the disease, PPIs.
Lucid Diagnostics Inc. ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: ...